{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Obesity Treatment: A Focus on Pharmacotherapy of Weight Management

Activity Steps


This article has been approved by the Orthopaedic Nurses Certification Board for Category B credit toward recertification as an ONC.

Purpose of Activity

To provide information on pharmacologic agents approved by the Food & Drug Administration (FDA) for weight loss.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Summarize the recommended uses, pharmacokinetics, potential benefits, and safety concerns related to the use of FDA-approved pharmacologic agents for weight loss.
  2. Identify contraindications for and adverse effects of pharmacologic weight loss agents.
Price: $20.00


  • ANCC 2.0 CH / 2.0 APH
  • DC - BON 2.0 CH
  • FL - BON 2.0 CH
  • GA - BON 2.0 CH

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Awarded Advanced Pharmacology Hours

Test Code: ON0320D
Published: Mar/Apr 2020
Expires: 3/4/2022
Required Passing Score: 17/24 (70%)
Authors: Khyati Patel, PharmD, BCACP
Specialties: Orthopaedics, Pharmacy
Topics: Obesity